The HSV-@ incidence rate was @ cases per @ person-years ( @ % confidence interval -LSB- CI -RSB- , @ to @ ) among @ women assigned to tenofovir gel , as compared with @ cases per @ person-years ( @ % CI , @ to @ ) among @ women assigned to placebo gel ( incidence rate ratio , @ ; @ % CI , @ to @ ; P = @ ) .